This assignment delves into the transmission of Creutzfeldt-Jakob Disease (CJD), a rare and fatal neurodegenerative disorder, primarily focusing on its spread via blood transfusions. It outlines historical incidents, policy responses by organizations like the UK government and the US FDA, and preventative measures implemented in various countries to minimize the risk of CJD transmission during blood donations, organ transplants, and other medical procedures involving bodily fluids.